Thrombin in ischemic neuronal death

Experimental Neurology

Volumn 198, Issue 1, 2006, Pages 199-203

  De Castro Ribeiro, Marlise ^a   Badaut, Jérôme ^a   Price, Melanie ^a   Meins, Marita ^b   Bogousslavsky, Julien ^a   Monard, Denis ^b   Hirt, Lorenz ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Hirudin; Neuroprotection; Organotypic hippocampal slice cultures; Oxygen and glucose deprivation; Protease nexin 1; Thrombin

Indexed keywords

HIRUDIN; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; GLUCOSE TRANSPORT; HIPPOCAMPUS; IMMUNOREACTIVITY; NERVE CELL NECROSIS; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; BLOTTING, WESTERN; CELL DEATH; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GLUCOSE; HIPPOCAMPUS; HIRUDIN THERAPY; HIRUDINS; ISCHEMIA; NEURONS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; THROMBIN;

EID: 32644436256     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.11.017     Document Type: Article

References (20)

1. J. Badaut, L. Hirt, M. Price, R.M. de Castro, P.J. Magistretti, and L. Regli Hypoxia/hypoglycemia preconditioning prevents the loss of functional electrical activity in organotypic slice cultures Brain Res. 1051 2005 117 122
2. F.M. Donovan, and D.D. Cunningham Signaling pathways involved in thrombin-induced cell protection J. Biol. Chem. 273 1998 12746 12752
3. F.M. Donovan, C.J. Pike, C.W. Cotman, and D.D. Cunningham Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities J. Neurosci. 17 1997 5316 5326
4. S. Gloor, K. Odink, J. Guenther, H. Nick, and D. Monard A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins Cell 47 1986 687 693
5. L. Hirt, J. Badaut, J. Thevenet, C. Granziera, L. Regli, F. Maurer, C. Bonny, and J. Bogousslavsky D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia Stroke 35 2004 1738 1743
6. C.E. Junge, T. Sugawara, G. Mannaioni, S. Alagarsamy, P.J. Conn, D.J. Brat, P.H. Chan, and S.F. Traynelis The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia Proc. Natl. Acad. Sci. U. S. A. 100 2003 13019 13024
7. T. Kamiya, C. Nito, M. Ueda, K. Kato, S. Amemiya, A. Terashi, and Y. Katayama Mild hypothermia enhances the neuroprotective effects of a selective thrombin inhibitor following transient focal ischemia in rats Acta Neurochir., Suppl. 86 2003 195 198
8. M. Karabiyikoglu, Y. Hua, R.F. Keep, S.R. Ennis, and G. Xi Intracerebral hirudin injection attenuates ischemic damage and neurologic deficits without altering local cerebral blood flow J. Cereb. Blood Flow Metab. 24 2004 159 166
9. H. Kawai, S. Yuki, J. Sugimoto, and Y. Tamao Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model J. Pharmacol. Exp. Ther. 278 1996 780 785
10. S. Kobayashi, and Y. Tazaki Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis Semin. Thromb. Hemost. 23 1997 531 534
11. M.P. LaMonte, M.L. Nash, D.Z. Wang, A.R. Woolfenden, J. Schultz, M.J. Hursting, and P.M. Brown Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study Stroke 35 2004 1677 1682
12. F. Markwardt The development of hirudin as an antithrombotic drug Thromb Res. 74 1994 1 23
13. T. Mima, Y.J. Jin, T. Hirayama, M.G. Mostafa, and K. Mori Argatroban, a thrombin inhibitor, decreased mortality after 10 min of forebrain ischemia in the gerbil Neurosci. Lett. 279 2000 93 96
14. H. Ohyama, N. Hosomi, T. Takahashi, K. Mizushige, and M. Kohno Thrombin inhibition attenuates neurodegeneration and cerebral edema formation following transient forebrain ischemia Brain Res. 902 2001 264 271
15. M. Riek-Burchardt, F. Striggow, P. Henrich-Noack, G. Reiser, and K.G. Reymann Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors Neurosci. Lett. 329 2002 181 184
16. J. Sommer, B. Meyhack, G. Rovelli, R. Buergi, and D. Monard Synthesis of glia-derived nexin in yeast Gene 85 1989 453 459
17. L. Stoppini, P.A. Buchs, and D. Muller A simple method for organotypic cultures of nervous tissue J. Neurosci. Methods 37 1991 173 182
18. F. Striggow, M. Riek-Burchardt, A. Kiesel, W. Schmidt, P. Henrich-Noack, J. Breder, M. Krug, K.G. Reymann, and G. Reiser Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia Eur. J. Neurosci. 14 2001 595 608
19. The International Stroke Trialists The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group Lancet 349 1997 1569 1581
20. S.E. Tsirka Tissue plasminogen activator as a modulator of neuronal survival and function Biochem. Soc. Trans. 30 2002 222 225